Bellevue Asset Management, LLC Organon & Co. Transaction History

Bellevue Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	SELL	$19.27 - $24.63 $1,927 - $2,463	-100 Reduced 62.11%	61 $1,000
Q1 2023 May 09, 2023	BUY	$21.42 - $32.08 $21 - $32	1 Added 0.63%	161 $3,000
Q3 2022 Nov 07, 2022	SELL	$23.4 - $34.25 $444 - $650	-19 Reduced 10.61%	160 $4,000
Q2 2022 Aug 12, 2022	BUY	$31.66 - $38.9 $31 - $38	1 Added 0.56%	179 $6,000
Q2 2021 Aug 09, 2021	BUY	$28.45 - $38.0 $5,064 - $6,764	178 New	178 $5,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Bellevue Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bellevue Asset Management, LLC with notifications on news.